Navigation Links
Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
Date:11/1/2011

DEERFIELD, Ill., Nov. 1, 2011 /PRNewswire/ -- Takeda Global Research & Development Center, Inc., (Takeda) announced that the U.S. Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 25, 2012 for the review of its investigational type 2 diabetes therapy alogliptin, and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.  

Currently, the FDA is reviewing the new drug applications (NDA) for the investigational therapies, which were resubmitted on July 25, 2011; the FDA has categorized these as Class 2 responses, requiring up to six months for review. Alogliptin is a selective dipeptidyl peptidase IV inhibitor (DPP-4i) under investigation in the United States (U.S.) for the treatment of type 2 diabetes as an adjunct to diet and exercise. Discovered by Takeda San Diego, Inc., alogliptin is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide), which play a role in regulating blood glucose levels. Pioglitazone was approved in 1999 for the treatment of type 2 diabetes as an adjunct to diet and exercise. If approved, alogliptin/pioglitazone will be the first type 2 diabetes treatment option in the U.S. to include both a DPP-4 inhibitor and a thiazolidinedione (TZD) in a single tablet.

According to the International Diabetes Federation, a staggering 285 million individuals were living with diabetes worldwide in 2010.

"As recent figures indicate that diabetes continues to be a serious global health challenge, Takeda remains deeply committed to researching new and important therapeutic options for patients living with type 2 diabetes," said David Recker, M.D., senior vice president, clinical science, Takeda Global Research & Development Center. "Phase 3 studies have demonstrated that the combination of a
'/>"/>

SOURCE Takeda Global Research & Development Center, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
2. Takeda Completes Acquisition and Names New CEO of Nycomed
3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
4. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
5. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
6. Takeda to Acquire Nycomed
7. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
8. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
11. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company ... to address unmet needs in large, well-defined and underserved ... executive officer and co-founder of BioPharmX, will present at ... on Wednesday, March 11 at 9:00 a.m. PDT at ... Dana Point , California.   ...
(Date:3/3/2015)... , March 3, 2015  UnaliWear announces the market ... support for seniors that guards against wandering and provides ... The new wearable – the Kanega watch ( http://www.UnaliWear.com ... to use an easy speech interface rather than buttons, ... without human input. The watch goes ...
(Date:3/3/2015)... -- American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) a ... in the design, development and production of innovative ... device companies has announced the acquisition of MTI ... cable manufacturer based in North Carolina.  The new ... name MTI Medical Cables.  The ...
Breaking Medicine Technology:BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2American Biosurgical Acquires MTI Corporation 2
... 2011 Cardica, Inc. (Nasdaq: CRDC ) today ... 30, 2011. Cardica,s management will host a conference call at ... and provide an update on the company,s business. ... Dr. Swanstrom, a world-renowned key opinion leader in laparoscopic surgery, ...
... ($ in millions, except per share data, unaudited)ItemQ3 2011Q3 ... Net Product Revenue , $112.9 , 16.9% increaseNaglazyme Net ... Product Revenue* , $23.0 , $16.5Kuvan Net Product ... , $3.5 , 59.1% increaseGAAP Net Income (Loss) , ...
Cached Medicine Technology:Cardica Announces Fiscal 2012 First Quarter Financial Results 2Cardica Announces Fiscal 2012 First Quarter Financial Results 3Cardica Announces Fiscal 2012 First Quarter Financial Results 4Cardica Announces Fiscal 2012 First Quarter Financial Results 5Cardica Announces Fiscal 2012 First Quarter Financial Results 6BioMarin Announces Third Quarter 2011 Financial Results 2BioMarin Announces Third Quarter 2011 Financial Results 3BioMarin Announces Third Quarter 2011 Financial Results 4BioMarin Announces Third Quarter 2011 Financial Results 5BioMarin Announces Third Quarter 2011 Financial Results 6BioMarin Announces Third Quarter 2011 Financial Results 7BioMarin Announces Third Quarter 2011 Financial Results 8BioMarin Announces Third Quarter 2011 Financial Results 9BioMarin Announces Third Quarter 2011 Financial Results 10BioMarin Announces Third Quarter 2011 Financial Results 11BioMarin Announces Third Quarter 2011 Financial Results 12BioMarin Announces Third Quarter 2011 Financial Results 13
(Date:3/3/2015)... Dr. Michael Nochomovitz has ... clinical integration and network development officer for ... established role, Dr. Nochomovitz is responsible for ... physician enterprise, its integration within NewYork-Presbyterian and ... Physicians. , Dr. Nochomovitz brings 17 years ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois ... pleased to announce that all Rabbit brand air purifiers are ... the west coast port strikes. This news comes just in ... , The port strikes, which have caused significant ... economic growth by as much as 1%, have hindered the ...
(Date:3/3/2015)... it is clear that the prospect of reduced premiums ... signing up to UBI policies, more mature audiences may ... to current regulations, the application of UBI in Canada ... capability is starting to be realised in the US ... are at the top of the value-added services wish-list. ...
(Date:3/3/2015)... York, NY (PRWEB) March 03, 2015 Daylight ... this spring. Sanjeev Kothare, MD, has tips for parents. , ... come March 8 at 2:00 a.m. when they set their ... when you wake up that day -- one hour earlier ... , That’s why parents should start thinking about “sleep hygiene” ...
(Date:3/3/2015)... The first week of March is Sleep ... event brings recognition to a rarely discussed problem that ... to the Centers for Disease Control , 70 million ... another. Too little or unrestful sleep is associated with ... depression, and even a higher likelihood of obesity. ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3
... 27 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... marketer of medical devices worldwide, today announced ... executive officer, Mr. Minghe,Cheng, Mindray,s executive vice ... Mindray,s investor relations manager, will attend the ...
... electronic health records now available worldwide, ... General Lt. Gen.,Eric B. Schoomaker today announced ... a comprehensive electronic health record,led by the ... or MC4,provides digital recording capabilities and access ...
... OAK BROOK, Ill. A new calcium scoring method may ... a new multicenter study published in the June issue of ... only the amount of calcified plaque build-up in the coronary ... the location of the calcium in the arteries is particularly ...
... summer days ahead and the,delights of a good book ... "Lifeliner: The Judy Taylor story," the debut book from ... inspiring summer read, it tells the poignant story of ... first person to live,decades on intravenous feeding without eating ...
... Nearly half of patients with a history of heart disease ... and do not perceive themselves to have an elevated cardiovascular ... of Archives of Internal Medicine, one of the JAMA/Archives journals. ... times the risk of having a heart attack or dying ...
... DALLAS May 26, 2008 Adding noninvasive imaging ... are at risk of developing heart disease, UT Southwestern ... from the UT Southwestern-led Dallas Heart Study to determine ... for calcium deposits and blockages could identify more people ...
Cached Medicine News:Health News:Mindray to Attend Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:Life-Saving Technology Expands Globally to Military Branches - Transforming the Way Medical Care is Documented on the Battlefield 2Health News:Coronary calcium distribution tied to heart attack risk 2Health News:An Inspiring Summer Read: Biography of Judy Taylor - The Woman Who Could Not Eat 2Health News:Many patients with heart disease have poor knowledge of heart attack symptoms 2Health News:Many patients with heart disease have poor knowledge of heart attack symptoms 3Health News:Increased screening may better predict those at higher risk for heart disease, researchers report 2
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
... Ezy Wrap® Economy ... urethane foam with synthtic ... be reversed for flexion ... Hand wash, air dry. ...
... improves patient compliance, prevent skin breakdown ... user's anatomy, wicks moisture, and evenly ... shoulders and upper throacic. Fits upright ... airflow openings. Adjustable Occipital Support Strap™ ...
... stabilization for muscles and ligaments to aid ... discomfort. Strong elastic abdominal belt provides ... degrees of compression. Two semi-rigid metal ... support. Tapered in front for optimum ...
Medicine Products: